IXHL Incannex Healthcare Limited - ADR

$IXHL I had a really vivid dreams last night about my portfolio suddenly jumping to a specific number due to IXHL. Working it back, the jump was due to a$750m Buyout or a jump to c. $55/share. Wouldn't be unhappy with that particular dream coming true

$IXHL Everyday i think about averaging down a bit....and everyday i'm glad i didn't cos it goes lower 🤣🤣🤣

$IXHL Happy Monday Bulls, Block out the noise, fundamentals haven't changed, a week closer to Dreamzz results. I'm not convinced PSX is stopped indefinetley. trial restructure or licensing deal with someone IMO.

$IXHL Since Q1 the ATM was cancelled and the entire focus is on IHL-42X. 70M in the bank. Zero debt. All-In DReAMzz moving forward. Capital runway of 12 months. By halting PSX-001 and putting IHL-675A on the back burner, Incannex eliminates millions in recurring operational costs tied to multi-site psilocybin trial logistics, therapist oversight, and separate clinical advisory infrastructure. Now 100% Capital preservation for their OSA asset. Massive OSA TAM: Sleep apnea affects tens of millions of people globally, and ~50% of patients abandon CPAP machines due to discomfort. Dr. Lou Barbato is Incannex's lead on IHL-42X and Chief Medical Officer. The company has highlighted his experience in clinical development and operations at Jazz Pharmaceuticals, AbbVie, Biogen, Novartis and Solvay, including involvement in drug development and product launches. Incannex has also stated that DReAMzz was shaped by its clinical advisory board and incorporated FDA feedback.

$IXHL sentiment is detached from actual business progression. Stronger financially than ever. IP has established a solid moat. IHL-42X is game changer. Only thing people struggling to cope with is time.

$IXHL The bears are working themselves into a frenzy. Must keep the sp under $3 so they are out in force peddling their bs.

$IXHL This is interesting. I verified this with two of my AI tools. Because $IXHL holds roughly $70M in cash against low total liabilities, their Stockholders' Equity far exceeds Nasdaq's $2.5 million requirement. If Nasdaq ever flagged them under the $35M market value rule, management wouldn't even need to raise capital or execute a split—they could simply elect to comply via the Stockholders' Equity standard on their standard reporting disclosures. This reinforces why management isn't panicking into an emergency capital raise or buyback—their heavy cash balance protects their listing status behind the scenes regardless of short-term price fluctuations. If you believe DReAMzz will be successful it may not be a bad idea to buy these dips. Jmo

$IXHL I called one of the recruitment centers and asked questions. Even though stockro advised me not to, and most perma bulls have blocked me…I want some real information. What they told me was that the study is 7 months, they are still recruiting people , they are only seeing people who are diagnosed with OSA but do NOT use a CPAP machine. So not sure how many people are actually participating because you can’t participate if you use a CPAP. Not sure how they can determine efficacy when they don’t test patients using a CPAP. I asked how long they are accepting new patients and she said there is no cut off date to enroll. I asked if people are enrolled and if it’s helping them (I know she can’t tell me) she said yes there are people enrolled. So this is a very long phase 2 journey. I got back in at 2.96 So I’m down yet again.

$IXHL brutal days are when bears come out to play. Long hold. One PR can turn this into a 250M+ MC. Waiting for that day…

$IXHL The Russell index is really taking it on the chin. Inflation. Fuel prices. AI slowly taking over. Politicians trading stocks. Bulls throwing in the towel. It’s rough out there. Until things change, enjoy most days. My plan is to eat well—not perfectly—and keep exercising. A piece of food dropped off my fork at dinner yesterday and fell all the way into my lap. I’ll take that as a win. 😂 Seriously, a trading friend told me years ago, “It’s great making money, but it’s more important to be healthy enough to spend it.” That advice has stuck with me. Markets will have their ups and downs. We can’t control everything happening around us, but we can control how we take care of ourselves and each other. Maybe we’ll get some positive news in the meantime. Every day brings us one day closer. If we can block out the noise, keep things in perspective, and enjoy life along the way, all the better.

$IXHL On May 14, 2025, IXHL surged approximately 876% following the announcement that Phase 2 patient dosing had been completed — not even the actual trial results. Subsequently inJuly 2025 July 24: +61.39% July 25: −35.58% July 28: +13.33% July 29: −10.08% July 30: −17.76% (positive Phase 2 results announced) July 31: −33.52% The stock skyrocketed on completion of dosing, yet declined when positive clinical results were actually released. So I don’t even know what to think about Dreamz results. Doubt will go up 876% again, but if it did that would be $28.30 ( .94 pre reverse split pricing )

$IXHL they know exactly what they are doing and who they are speaking to. Very exciting.

$IXHL The market is focused on the share price. I’m focused on the clinical progress. Incannex is no longer just a pipeline concept. It’s a clinical-stage biotech advancing treatments in multibillion-dollar markets, backed by a growing IP portfolio. The valuation reflects substantial scepticism. The potential catalysts could change that narrative entirely. Price reflects sentiment. Clinical results will determine value. The disconnect is where the opportunity lies.

$IXHL Joel has a twisted sense of humor, no noubt ;) “Transparent communication is essential throughout this process. Investors and other stakeholders need a clear understanding of development progress. Setting realistic expectations and explaining strategic decisions can strengthen credibility during periods of uncertainty.“

$IXHL It’s not enjoyable currently being pretty much locked into this stock but I still have the belief that there’s cogs turning in the background. As much as we love to bag 56 foreheads, it’s not him I’m believing in , it’s the results to date and top notch medical teams working on the trials. Time is flying so won’t be that long really till DReAMzz comes front and centre. Still here , still bullish as the wait goes on. GLTAHs

$IXHL so the bear narrative has been the drug is rubbish and is a failure coupled with the ceo is a crook, useless at his job. Now we’re getting the drug is good but still management is rubbish. I guess they’re slowly coming round to the fact this is a good investment.

$IXHL There are many good people here, and many that mean well but are part-time delusional, especially to folks like me, that try to stay transparent, help others learn to trade biotech stocks. The end point is for everyone to trade how they see fit, whether your long-term, short-term, flipper or swinger, to secure profits for ourselves and our families. Sharing with others a profit and how they obtained it is not welcome here. People don't even know 20% of what they should know as investors. They comment on strictly emotion, and not facts, as if what anyone posts here will make a difference. That's why you have bears. You shouldn't have to hear nonsense from the very people you think are on your side.

$IXHL In its completed RePOSA Phase 2 trial, IHL-42X actually reduced average AHI by 44.4% across all treatment groups, with the low- and high-dose cohorts showing maximum individual AHI reductions of 79% and 83% respectively. In fact, 60% of participants in that trial experienced an AHI reduction greater than 50% during at least one treatment period. Just saying bears

$IXHL this phase 2 will take about a year. It’s a seven month trial and still recruiting. This SP has now left the 3’s and with no catalysts will be going lower and lower.

$IXHL I think PSX is a tough sell to any partner. Doesn’t it require both the therapist and patient to microdose during therapy sessions? If so, the complexities of commercialization have to make any suitor incredibly cautious. Open to hearing counterpoints. But I invested for 42x, so any positivity from PSX is gravy to me